Serious risks, including kidney strain, liver issues, allergic reactions, and rare cases of Stevens-Johnson syndrome, are linked to high doses, counterfeit vials, and unsupervised administration
Multi-agonist stacks like CagriSema (cagrilintide + semaglutide) involve a different class partner (amylin), which is the only validated multi-peptide fat-loss protocol to date
The interaction profile, while not dangerous in most cases, requires professional oversight to manage effectively
Step 6: continue your regular dosing schedule Take your next dose at the normally scheduled time
Quality counts too
A detailed dosage chart for weight loss could look like: Initial Phase During the initial phase, a lower dose of 2.5 mg once a week is recommended